BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8091675)

  • 1. Exchange of functional domains between Rev proteins of HIV-1 and SIVmac239 results in a dominant negative phenotype.
    Berchtold S; Ries J; Hornung U; Aepinus C
    Virology; 1994 Oct; 204(1):436-41. PubMed ID: 8091675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
    Rizvi TA; Schmidt RD; Lew KA; Keeling ME
    Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation domain of simian immunodeficiency virus SIVmac239 Rev protein is structurally and functionally analogous to the HIV-1 Rev activation domain.
    Berchtold S; Hornung U; Aepinus C
    Virology; 1995 Aug; 211(1):285-9. PubMed ID: 7645223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence requirements for Rev multimerization in vivo.
    Madore SJ; Tiley LS; Malim MH; Cullen BR
    Virology; 1994 Jul; 202(1):186-94. PubMed ID: 7516596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.
    Stauber RH; Afonina E; Gulnik S; Erickson J; Pavlakis GN
    Virology; 1998 Nov; 251(1):38-48. PubMed ID: 9813201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General effect of Sam68 on Rev/Rex regulated expression of complex retroviruses.
    Reddy TR; Xu WD; Wong-Staal F
    Oncogene; 2000 Aug; 19(35):4071-4. PubMed ID: 10962565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 by a double transdominant fusion gene.
    Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
    Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element.
    Daly TJ; Rennert P; Lynch P; Barry JK; Dundas M; Rusche JR; Doten RC; Auer M; Farrington GK
    Biochemistry; 1993 Aug; 32(34):8945-54. PubMed ID: 8364040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    Modem S; Reddy TR
    J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; CastaƱo ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal.
    Zhang J; Liu Y; Henao J; Rugeles MT; Li J; Chen T; He JJ
    Gene; 2005 Dec; 363():67-76. PubMed ID: 16236470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titration of cellular export factors, but not heteromultimerization, is the molecular mechanism of trans-dominant HTLV-1 rex mutants.
    Heger P; Rosorius O; Hauber J; Stauber RH
    Oncogene; 1999 Jul; 18(28):4080-90. PubMed ID: 10435589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ; Taylor MD; Katze MG
    Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
    Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
    Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.